prednisolone has been researched along with Glucose Intolerance in 10 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Increased prednisolone dose and older age are strongly associated with the development of posttransplant glucose intolerance." | 7.69 | Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. ( Egeland, T; Fauchald, P; Hartmann, A; Hjelmesaeth, J; Kofstad, J; Leivestad, T; Stenstrøm, J, 1997) |
| "Men with the metabolic syndrome but without diabetes received prednisolone 30 mg once daily plus sitagliptin 100 mg once daily (n=14), prednisolone (n=12) or sitagliptin alone (n=14) or placebo (n=12) for 14 days in a double-blind 2 × 2 randomized-controlled study." | 5.19 | Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial. ( Diamant, M; Heymans, MW; Mari, A; Muskiet, MH; Ouwens, DM; Pouwels, PJ; van Genugten, RE; van Raalte, DH, 2014) |
| " Intravenous boluses of cyclophosphamide (IVCY) with oral prednisolone and cyclosporin A induced remission of SLE, and a subsequent disappearance of anti-insulin receptor autoantibodies, followed by a recovery of glucose intolerance." | 3.76 | Type B insulin resistance complicated with systemic lupus erythematosus. ( Aramaki, T; Eguchi, K; Fujikawa, K; Ida, H; Iwamoto, N; Kawakami, A; Kawashiri, SY; Nakamura, H; Origuchi, T; Tamai, M, 2010) |
| " This study reports the use of a large dose of prednisolone to evaluate the effects of EA in a state of insulin resistance." | 3.75 | Acute effect of electroacupuncture at the Zusanli acupoints on decreasing insulin resistance as shown by lowering plasma free fatty acid levels in steroid-background male rats. ( Chang, SL; Cheng, JT; Ho, WJ; Lee, YC; Lin, JG; Lin, RT; Tzeng, CY, 2009) |
| "Increased prednisolone dose and older age are strongly associated with the development of posttransplant glucose intolerance." | 3.69 | Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. ( Egeland, T; Fauchald, P; Hartmann, A; Hjelmesaeth, J; Kofstad, J; Leivestad, T; Stenstrøm, J, 1997) |
| "Both Mikulicz's disease and autoimmune pancreatitis presented with elevated serum IgG4 and infiltration of IgG4-expressing plasma cells into the glandular tissues." | 1.33 | [A case of Mikulicz's disease complicated by autoimmune pancreatitis, in which impaired glucose tolerance was improved by glucocorticoid treatment]. ( Imai, K; Naishiro, Y; Ohara, M; Oka, T; Shinomura, Y; Suzuki, C; Takahashi, H; Yamamoto, H; Yamamoto, M, 2005) |
| "Glucose intolerance is an untoward side effect of some immunosuppressive and anti-hypertensive drugs." | 1.31 | Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. ( Egeland, T; Fauchald, P; Hartmann, A; Hjelmesaeth, J; Kofstad, J; Stenstrøm, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noguchi, K | 1 |
| Nakai, Y | 1 |
| Mizuno, S | 1 |
| Isayama, H | 1 |
| Hirano, K | 1 |
| Kanai, S | 1 |
| Nakamura, T | 1 |
| Uchino, R | 1 |
| Takahara, N | 1 |
| Kogure, H | 1 |
| Tada, M | 1 |
| Koike, K | 1 |
| van Genugten, RE | 1 |
| van Raalte, DH | 1 |
| Muskiet, MH | 1 |
| Heymans, MW | 1 |
| Pouwels, PJ | 1 |
| Ouwens, DM | 1 |
| Mari, A | 1 |
| Diamant, M | 1 |
| Lin, RT | 1 |
| Tzeng, CY | 1 |
| Lee, YC | 1 |
| Ho, WJ | 1 |
| Cheng, JT | 1 |
| Lin, JG | 1 |
| Chang, SL | 1 |
| Kawashiri, SY | 1 |
| Kawakami, A | 1 |
| Fujikawa, K | 1 |
| Iwamoto, N | 1 |
| Aramaki, T | 1 |
| Tamai, M | 1 |
| Nakamura, H | 1 |
| Origuchi, T | 1 |
| Ida, H | 1 |
| Eguchi, K | 1 |
| Yamamoto, M | 1 |
| Ohara, M | 1 |
| Suzuki, C | 1 |
| Oka, T | 1 |
| Naishiro, Y | 1 |
| Yamamoto, H | 1 |
| Takahashi, H | 1 |
| Shinomura, Y | 1 |
| Imai, K | 1 |
| Hokken-Koelega, AC | 1 |
| Hjelmesaeth, J | 2 |
| Hartmann, A | 2 |
| Kofstad, J | 2 |
| Stenstrøm, J | 2 |
| Leivestad, T | 1 |
| Egeland, T | 2 |
| Fauchald, P | 2 |
| Uchida, K | 1 |
| Tominaga, Y | 1 |
| Haba, T | 1 |
| Katayama, A | 1 |
| Ichimori, T | 1 |
| Yamada, K | 1 |
| Hibi, Y | 1 |
| Uemura, O | 1 |
| Morozumi, K | 1 |
| Takagi, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism and Beta-Cell Dysfunction in Males With the Metabolic Syndrome X: A Randomized, Placebo-controlled, Double-blind Intervention Study With a 2x2 Factorial Design[NCT00721552] | 82 participants (Actual) | Interventional | 2008-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisolone and Glucose Intolerance
| Article | Year |
|---|---|
Deflazacort--an alternative to prednisolone?
Topics: Adult; Anti-Inflammatory Agents; Child; Glucocorticoids; Glucose Intolerance; Humans; Prednisolone; | 1999 |
2 trials available for prednisolone and Glucose Intolerance
| Article | Year |
|---|---|
Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; F | 2014 |
Decreasing pancreatic toxicity of tacrolimus by dosage reduction.
Topics: Administration, Oral; Blood Glucose; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Thera | 1998 |
7 other studies available for prednisolone and Glucose Intolerance
| Article | Year |
|---|---|
Insulin secretion improvement during steroid therapy for autoimmune pancreatitis according to the onset of diabetes mellitus.
Topics: Aged; Anti-Inflammatory Agents; Atrophy; Autoimmune Pancreatitis; Blood Glucose; C-Peptide; Diabetes | 2020 |
Acute effect of electroacupuncture at the Zusanli acupoints on decreasing insulin resistance as shown by lowering plasma free fatty acid levels in steroid-background male rats.
Topics: Acupuncture Points; Animals; Blood Glucose; Disease Models, Animal; Electroacupuncture; Fatty Acids, | 2009 |
Type B insulin resistance complicated with systemic lupus erythematosus.
Topics: Autoantibodies; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glucose Intolerance; Huma | 2010 |
[A case of Mikulicz's disease complicated by autoimmune pancreatitis, in which impaired glucose tolerance was improved by glucocorticoid treatment].
Topics: Aged; Autoimmune Diseases; Female; Glucocorticoids; Glucose Intolerance; Humans; Mikulicz' Disease; | 2005 |
Can glucose intolerance and/or diabetes be predicted in patients treated with rhGH?
Topics: Child; Diabetes Mellitus; Glucose Intolerance; Human Growth Hormone; Humans; Kidney Transplantation; | 1996 |
Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.
Topics: Adult; Age Factors; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Family; Femal | 1997 |
Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cyclosporine; Female; Glucose Intolerance; Glucose Tolerance | 2001 |